KTTA vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Captures Institutional Edge (2โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical while ENSC counters with relative strength in Valuation. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KTTA Revenue | ENSC Revenue | KTTA Op. Margin | ENSC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | N/A | $0M | N/A | -41.0% | ENSC |
| FY2021 | $0M | $0M | -29925.7% | -562.7% | ENSC |
| FY2022 | $0M | $0M | -2587.3% | -959.9% | ENSC |
| FY2023 | N/A | $0M | N/A | -480.5% | ENSC |
| FY2024 | N/A | $10M | N/A | -129.2% | ENSC |
| FY2025 | N/A | $10M | N/A | -202.1% | ENSC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KTTA | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.7M | $7.0M | Larger Scale | KTTA |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | +1498.1% | -15.1% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | 0.0% | -281.3% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | -280.5% | Higher Margin | KTTA |
| Return on Equity (ROE) Capital Efficiency | -88.8% | -1295.1% | Higher ROE | KTTA |
| 52-Week Range Position Momentum | 11% ($0โ$2) | 8% ($0โ$2) | Stronger Trend | KTTA |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 185% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |